TTMI Form 144: 3,484 Restricted Shares Proposed for Sale on Nasdaq
Rhea-AI Filing Summary
TTM Technologies disclosed a proposed sale of 3,484 common shares to be executed through Morgan Stanley Smith Barney on NASDAQ with an aggregate market value of $162,292.73. The company reports 103,313,274 shares outstanding, so this block represents a very small fraction of the outstanding equity. The shares were acquired as restricted stock from the issuer on 06/22/2023 (3,105 shares), 05/06/2023 (154 shares) and 02/01/2024 (225 shares). The filing notes no securities sold in the past three months and includes the signer’s representation that no undisclosed material adverse information exists.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small, routine insider sale; unlikely to move the market given the tiny percentage of outstanding shares.
The filing notifies a proposed sale of 3,484 shares valued at $162,292.73, versus 103,313,274 shares outstanding. That is approximately 0.0034% of the outstanding shares, indicating the transaction is immaterial to market capitalization. The use of Morgan Stanley Smith Barney as broker and the disclosure of acquisition as restricted stock are consistent with routine, compliant dispositions under Rule 144. No sales in the past three months further reduce the chance of signalling near-term insider pattern risk.
TL;DR: Filing appears procedural and compliant; restricted-stock origin and absence of recent sales reduce governance concerns.
The notice documents that the shares were granted as restricted stock across 2023 and 2024 and that the seller affirms no material nonpublic information. The specified broker and the formal Rule 144 notice suggest adherence to reporting and trading-planning protocols. Given the small share count relative to total outstanding shares and the statement of no recent sales, this disclosure does not indicate a significant governance event or unusual insider activity.
FAQ
What does the TTMI Form 144 disclose about the proposed sale?
When is the proposed sale scheduled and on which exchange?
How were the securities being sold originally acquired?
Has the filer sold any securities of the issuer in the past three months?
Who is the broker handling the proposed sale?